ESR1 and breast cancer: To validate our findings and to extend our analysis beyond the TCGA data set, we performed KCNJ3 RNA in situ hybridization (ISH) on 66 breast cancer patient samples that were available with clinical data and follow-up times from the estrogen receptor positive cohort GSE17705.